银诺医药－Ｂ(02591)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02591 银诺医药－Ｂ

提前休市 12-24 12:08:22

32.180

+0.480

+1.51%

最高32.400	最低31.620	成交量14.80万
今开31.680	昨收31.700	日振幅2.46%
总市值147.00亿	流通市值135.25亿	总股本4.57亿
成交额470.61万	换手率0.04%	流通股本4.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02591","market":"HK","secType":"STK","nameCN":"银诺医药－Ｂ","latestPrice":32.18,"timestamp":1766549302752,"preClose":31.7,"halted":0,"volume":148000,"delay":0,"floatShares":420285370,"shares":456819349,"eps":-0.4619653952815664,"marketStatus":"提前休市","change":0.48,"latestTime":"12-24 12:08:22","open":31.68,"high":32.4,"low":31.62,"amount":4706116,"amplitude":0.024606,"askPrice":32.18,"askSize":1200,"bidPrice":31.62,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-0.5859044344255921,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":6,"adr":0,"listingDate":1755187200000,"exchange":"SEHK","adjPreClose":31.7,"openAndCloseTimeList":[[1766539800000,1766548800000]],"volumeRatio":0.49686,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02591","defaultTab":"news","newsList":[{"id":"2593497421","title":"银诺医药-B荣获“格隆汇金格奖·年度卓越创新力IPO”奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2593497421","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593497421?lang=zh_cn&edition=full","pubTime":"2025-12-23 20:27","pubTimestamp":1766492822,"startTime":"0","endTime":"0","summary":"格隆汇12月22日线上举办“科技赋能·资本破局”分享会。备受瞩目的卓越公司评选榜单隆重揭晓。其中，格隆汇“金格奖”年度卓越公司评选中，银诺医药-B(02591.HK)荣获“年度卓越创新力IPO”奖项。\r\n\r\n　　“年度卓越创新力IPO”奖项是对公司过去一年在产品创新、模式创新、组织创新等方面进行考量，旨在表彰以持续创新紧跟市场步伐，在模式与路径上获得优秀成果的新上市公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251223/31885620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2592950361","title":"港股异动 | 银诺医药-B(02591)盘中涨超3% 依苏帕格鲁肽ɑ获国家基层糖尿病防治指南推荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2592950361","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592950361?lang=zh_cn&edition=full","pubTime":"2025-12-17 11:00","pubTimestamp":1765940420,"startTime":"0","endTime":"0","summary":"消息面上，据银诺医药官微消息，在《\"健康中国2030\"规划纲要》推动糖尿病防治关口前移、提升创新药物可及性的战略部署下，中国原研首款超长效人源性GLP-1受体激动剂依苏帕格鲁肽α正式纳入2025版国家医保药品目录，适用于\"成人2型糖尿病患者的血糖控制\"，自2026年1月1日起正式执行。在《国家基层糖尿病防治管理指南 》中，依苏帕格鲁肽ɑ被列为注射类降糖药物的GLP-1RA周制剂，为基层医疗机构配备和使用该药提供了直接的政策与规范依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"1150760712","title":"港股异动｜生物医药股上扬，药捷安康涨超17%，昭衍新药涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1150760712","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150760712?lang=zh_cn&edition=full","pubTime":"2025-12-17 10:50","pubTimestamp":1765939813,"startTime":"0","endTime":"0","summary":"轩竹生物涨超5%，银诺医药涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"22a0e03e703ab82b83863db78ab69d04","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","02575","06127","02591"],"gpt_icon":0},{"id":"1176090511","title":"一周港股牛熊榜 |  长飞光纤光缆周内飙34%，AI算力基建热潮推动光通信需求；轩竹生物周升28%，轩悦宁进入医保目录；第一拖拉机周升21%获高盛看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1176090511","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176090511?lang=zh_cn&edition=full","pubTime":"2025-12-12 18:12","pubTimestamp":1765534337,"startTime":"0","endTime":"0","summary":"高速光模块、光纤光缆及相关配套设备的需求随之水涨船高。$轩竹生物-B$ 本周累升28.11%，轩悦宁进入医保目录，两款肿瘤产品年内密集获批轩竹生物近日宣布，创新药轩悦宁首次纳入国家基本医保药品目录。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f31f9c4b7b746092dc00ca030c9a8d42","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"一周港股牛熊榜 |  长飞光纤光缆周内飙34%，AI算力基建热潮推动光通信需求；轩竹生物周升28%，轩悦宁进...","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSTECH","02575","01072","00038","00108","06869","01618","02591","02643","HSI","06127","HSCEI","09678"],"gpt_icon":1},{"id":"1189663107","title":"港股综述 | 新股宝济药业涨近139%，图达通涨33%；黄金股、内房股走强，灵宝黄金涨超9%，万科企业涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1189663107","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189663107?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:40","pubTimestamp":1765356031,"startTime":"0","endTime":"0","summary":"港股行情港股三大指数齐涨，恒生指数涨0.42%，恒生科技指数涨0.48%，国企指数涨0.20%。此外，今日两只新股上市，宝济药业-B首日上市涨138.82%，图达通首日上市涨33%。猪肉股涨幅居前，惠生国际涨超9%，万洲国际涨超5%。$石药集团$涨超3%，司美格鲁肽注射液第二项上市许可申请获受理。$灵宝黄金$涨超9%，拟斥资17.35亿元收购巴布亚新几内亚金矿权益。A股行情A股三大指数涨跌不一，截至收盘，沪指跌0.23%报3900点，深证成指涨0.29%，创业板指跌0.02%。","market":"hk","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c285d9a76c27d3b07a8e1d710acacdec","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00815","HSI","02591","09987","HSTECH"],"gpt_icon":0},{"id":"2590374400","title":"港股银诺医药-B拉升逾23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590374400","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590374400?lang=zh_cn&edition=full","pubTime":"2025-12-10 11:00","pubTimestamp":1765335658,"startTime":"0","endTime":"0","summary":"每经AI快讯，银诺医药-B(02591.HK)逆市拉升逾23%。截至发稿涨23.38%，报39.44港元，成交额7649.49万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512103587513597.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512103587513597.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"1168169817","title":"银诺医药-B盘中强势拉升逾20%！近日公司正式入通，GLP-1受体激动剂怡诺轻®成功入保","url":"https://stock-news.laohu8.com/highlight/detail?id=1168169817","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168169817?lang=zh_cn&edition=full","pubTime":"2025-12-10 10:38","pubTimestamp":1765334310,"startTime":"0","endTime":"0","summary":"12月10日，银诺医药-B盘中强势拉升，现涨超20%！此前获调入港股通目标证券名单。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e2305d06222c3c37df21df74dd19759a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"2590148563","title":"银诺医药-B12月09日遭主力抛售155.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590148563","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590148563?lang=zh_cn&edition=full","pubTime":"2025-12-09 16:16","pubTimestamp":1765268166,"startTime":"0","endTime":"0","summary":"12月09日, 银诺医药-B股价跌14.69%，报收32.16元，成交金额5564.7万元，换手率0.40%，振幅15.38%，量比2.18。银诺医药-B今日主力资金净流出155.7万元，连续3日净流出，上一交易日主力净流出334.6万元。该股近5个交易日下跌15.43%，主力资金累计净流出399.3万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入2460.8万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209162340a72ceb5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209162340a72ceb5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2589351282","title":"港股公告掘金 | 果下科技拟全球发售3385.29万股H股 引入惠开香港等基石投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2589351282","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589351282?lang=zh_cn&edition=full","pubTime":"2025-12-08 23:02","pubTimestamp":1765206176,"startTime":"0","endTime":"0","summary":"重大事项：果下科技(02655)12月8日至12月11日招股 拟全球发售3385.29万股H股 引入惠开香港等基石投资者基石药业-B(02616)：普吉华(普拉替尼胶囊)获纳入2025年国家医保目录四环医药(00460)：创新药轩悦宁首次纳入国家基本医保药品目录上海医药(02607)：氨磺必利口崩片通过国家医保谈判并成功纳入国家医保目录翰森制药(03692)：创新药阿美乐新增两项适应症成功纳入新版","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379071.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999001069.SGD","LU0449515922.USD","SG9999001051.SGD","SGXZ90724238.SGD","00489","BK1539","BK1503","SG9999003461.SGD","LU0054450605.USD","BK1148","BK1166","SG9999006597.SGD","BK1583","BK1154","LU0823040885.USD","HK0000252152.HKD","SG9999001093.SGD","LU0254981946.USD","00956","HK0000500386.USD","BK1240","BK1523","02655","BK1558","BK1565","00916","BK1594","BK1161","LU0449509016.USD","HK0000252160.HKD","LU0531970944.HKD","02591","BK1119","SG9999002950.SGD","06166","BK1149","01618","LU0214875030.USD"],"gpt_icon":0},{"id":"2590686553","title":"银诺医药-B12月08日遭主力抛售334.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590686553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590686553?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:15","pubTimestamp":1765181754,"startTime":"0","endTime":"0","summary":"12月08日, 银诺医药-B股价跌14.32%，报收37.70元，成交金额5501.7万元，换手率0.33%，振幅16.82%，量比2.23。银诺医药-B今日主力资金净流出334.6万元，上一交易日主力净流出49.6万元。该股近5个交易日下跌4.75%，主力资金累计净流出210.1万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入2897.3万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208162059a43af1d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208162059a43af1d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2589812573","title":"重磅消息！这些上市药企“明星药”进保","url":"https://stock-news.laohu8.com/highlight/detail?id=2589812573","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589812573?lang=zh_cn&edition=full","pubTime":"2025-12-08 14:08","pubTimestamp":1765174090,"startTime":"0","endTime":"0","summary":"12月8日，A股医药概念股震荡走强，荣科科技20cm涨停，合富中国“一字”涨停，华是科技涨超10%领涨，瑞康医药开盘涨停后开板，随后维持高位震荡走势。消息面上，12月7日，国家医保局正式发布调整后的国家基本医保目录，以及首版商保创新药目录。调整后，基本医保目录内药品总数增至3253种，其中西药1857种、中成药1396种。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512083585205218.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512083585205218.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","01276","LU2543165471.USD","LU0359201612.USD","02591","PMF","BK1161","LU1023057109.AUD","LU0359201885.HKD","LU0359202008.SGD"],"gpt_icon":0},{"id":"2589850143","title":"银诺医药：超长效GLP-1受体激动剂成功纳入医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589850143","media":"生物药大时代","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589850143?lang=zh_cn&edition=full","pubTime":"2025-12-08 10:23","pubTimestamp":1765160602,"startTime":"0","endTime":"0","summary":"12月7日，银诺医药-B发布公告，董事会欣然宣布，公司核心产品依苏帕格鲁肽α已成功纳入中国最新版《国家医保药品目录》，用于治疗2型糖尿病。该目录将于2026年1月1日正式生效。依苏帕格鲁肽α是公司研发的国内首款原研人源长效GLP-1受体激动剂，并于2025年1月在中国获批用于单药治疗及联合二甲双胍治疗2型糖尿病。依苏帕格鲁肽α是全球第三个、亚洲首个进入商业化阶段的超长效GLP-1受体激动剂，也是中国本土原创的同类首款创新药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208110252a72a1757&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208110252a72a1757&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2589004768","title":"港股异动 | 银诺医药-B(02591)回吐逾13% 此前两周累计涨幅达50% 今日起正式进入港股通","url":"https://stock-news.laohu8.com/highlight/detail?id=2589004768","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589004768?lang=zh_cn&edition=full","pubTime":"2025-12-08 10:18","pubTimestamp":1765160320,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，银诺医药-B(02591)回吐逾13%，此前两周股价累计涨幅达50%。截至发稿，跌13.64%，报38港元，成交额3031.07万港元。消息面上，上交所、深交所发布公告称，因恒生综合中型股指数实施成份股调整，根据有关规定，港股通标的名单发生调整，将银诺医药调入港股通，自2025年12月8日起生效。此外，银诺医药宣布，公司自主研发的超长效GLP-1受体激动剂依苏帕格鲁肽α（怡诺轻®）正式纳入2025年国家医保药品目录，将自2026年1月1日起与新版目录同步实施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ea7f8bad5830eb56e7f8e7357923f6c6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378623.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"1157903379","title":"港股生物医药股重挫！荣昌生物跌超12%，银诺医药跌超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157903379","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157903379?lang=zh_cn&edition=full","pubTime":"2025-12-08 09:57","pubTimestamp":1765159066,"startTime":"0","endTime":"0","summary":"12月8日，港股生物医药股重挫，$荣昌生物(688331)$跌超12%，$银诺医药-B(02591)$跌超11%，$信达生物(01801)$、$乐普生物-B(02157)$、$来凯医药-B(02105)$跌超6%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ea7f8bad5830eb56e7f8e7357923f6c6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02591","BK1161","LU2488822045.USD","BK1574","LU1064131003.USD","BK0239","LU1064130708.USD","LU1969619763.USD","LU2148510915.USD","09995","LU2328871848.SGD"],"gpt_icon":0},{"id":"1172366349","title":"深交所：富卫集团、奥克斯电气、银诺医药-B、奇瑞汽车调入港股通标的证券名单","url":"https://stock-news.laohu8.com/highlight/detail?id=1172366349","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172366349?lang=zh_cn&edition=full","pubTime":"2025-12-08 08:53","pubTimestamp":1765155223,"startTime":"0","endTime":"0","summary":"12月8日，深交所：港股通标的证券名单调整，调入$富卫集团(01828)$、$奥克斯电气(02580)$、$银诺医药-B(02591)$、$奇瑞汽车(09973)$，12月08日起生效。","market":"hk","thumbnail":"https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e29b51015cdf4e4a25d560680be6b977","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"深交所：富卫集团、奥克斯电气、银诺医药-B、奇瑞汽车调入港股通标的证券名单","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02580","01828","02591","09973"],"gpt_icon":0},{"id":"2589874475","title":"银诺医药-B(02591)核心产品纳入《国家医保药品目录》","url":"https://stock-news.laohu8.com/highlight/detail?id=2589874475","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589874475?lang=zh_cn&edition=full","pubTime":"2025-12-07 19:19","pubTimestamp":1765106399,"startTime":"0","endTime":"0","summary":"智通财经APP讯，银诺医药-B(02591)发布公告，集团核心产品(即依苏帕格鲁肽α)已成功纳入中国最新版《国家医保药品目录》(2025年版)，用于治疗2型糖尿病(“ T2D”)适应症。最新版《国家医保药品目录》将于2026年1月1日正式生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378518.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"银诺医药-B(02591)核心产品纳入《国家医保药品目录》","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2589854273","title":"港股异动 | 银诺医药-B(02591)再涨超5% 下周一正式进入恒生综指 机构称其符合港股通纳入范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2589854273","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589854273?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:05","pubTimestamp":1764900344,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，银诺医药-B(02591)再涨超5%，股价暂现三连阳。截至发稿，涨5.03%，报43.42港元，成交额764.33万港元。消息面上，恒生指数系列季度检讨结果此前公布，其中，银诺医药获纳入恒生综合指数成份股，变动将于2025年12月8日起生效。据中金预测，银诺医药等符合港股通纳入范围。公开资料显示，银诺医药是一家专注于代谢性疾病领域的生物医药公司，目前拥有多项针对糖尿病、肥胖和非酒精性脂肪性肝炎等适应症的创新药物研发管线，全部为自主研发，具备全球知识产权，覆盖全球研发与市场布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378009.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2588882596","title":"银诺医药-B12月04日获主力加仓73.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588882596","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588882596?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:16","pubTimestamp":1764836164,"startTime":"0","endTime":"0","summary":"12月04日, 银诺医药-B股价涨5.41%，报收41.34元，成交金额1978.7万元，换手率0.12%，振幅6.17%，量比0.76。银诺医药-B今日主力资金净流入73.2万元，连续3日净流入，上一交易日主力净流入67.3万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为100.00%，平均涨幅为3.45%。该股近5个交易日下跌5.57%，主力资金累计净流入309.0万元；近20日主力资金累计净流入3187.8万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204162247a723519b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204162247a723519b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","BK1161"],"gpt_icon":1},{"id":"1153185179","title":"广州银诺医药（2591）11月股份变动月报：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1153185179","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153185179?lang=zh_cn&edition=full","pubTime":"2025-12-03 17:03","pubTimestamp":1764752618,"startTime":"0","endTime":"0","summary":"广州银诺医药集团股份有限公司于2025年12月3日发布2025年11月股份变动月报。公告显示，截至2025年11月30日，公司注册股本为人民币456,819,349元，包括420,285,370股在香港联交所上市的H股及36,533,979股非上市股份，面值均为每股人民币1元；本月内上述股数无增减变动。根据公告所载信息，本次月报由公司联席公司秘书金今签署，公司确认已遵守香港联交所上市规则及相关法律法规。综上所述，截至2025年11月末，公司股本保持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"2588028481","title":"银诺医药-B12月03日获主力加仓67.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588028481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588028481?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:15","pubTimestamp":1764749756,"startTime":"0","endTime":"0","summary":"12月03日, 银诺医药-B股价涨3.65%，报收39.22元，成交金额1432.3万元，换手率0.09%，振幅5.44%，量比0.51。银诺医药-B今日主力资金净流入67.3万元，上一交易日主力净流入33.5万元。该股近5个交易日下跌6.74%，主力资金累计净流入822.9万元；近20日主力资金累计净流入3370.9万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203162123978d74d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203162123978d74d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0246},{"period":"1month","weight":0.0946},{"period":"3month","weight":-0.2488},{"period":"6month","weight":0.697},{"period":"ytd","weight":0.697}],"compareEarnings":[{"period":"1week","weight":0.0213},{"period":"1month","weight":0.022},{"period":"3month","weight":-0.0281},{"period":"6month","weight":0.0596},{"period":"1year","weight":0.2963},{"period":"ytd","weight":0.2849}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"银诺医药成立于2014年,是一家科学驱动的生物制药公司,致力于为代谢性疾病患者提供创新的,可及且可负担的高质量药品。公司目前已拥有多项针对糖尿病、肥胖,代谢功能障碍相关适应症的研发管线,且所有管线均为自主研发,拥有全球专利,并布局全球研发和市场销售。\n公司首个管线产品依苏帕格鲁肽α(曾用名:苏帕鲁肽,商品名:怡诺轻)于2025年1月份获中国国家药品监督管理局批准上市,成为我国首个国产原研的人源化长效GLP-1受体激动剂产品,将惠及更多的糖尿病患者。公司同时在开发依苏帕格鲁肽α减肥和代谢功能障碍相关的脂肪性肝炎适应症,以满足这些疾病领域巨大的未满足治疗需求。\n银诺研发团队由国家特聘专家领衔,与具有多年创新药研发经验的科学家队伍组成,其创始人,董事长兼首席执行官,依苏帕格鲁肽α发明人王庆华博士是复旦大学特聘专家,十三五国家科技“重大新药创制”项目课题负责人。王庆华教授曾是多伦多大学的终身教授及世界领先的班廷百思特糖尿病研究所的常务委员。\n银诺医药拥有先进的重组蛋白生物药技术平台可用于创新生物药的持续研发。","exchange":"SEHK","name":"银诺医药－Ｂ","nameEN":"INNOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"银诺医药－Ｂ(02591)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供银诺医药－Ｂ(02591)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"银诺医药－Ｂ,02591,银诺医药－Ｂ股票,银诺医药－Ｂ股票老虎,银诺医药－Ｂ股票老虎国际,银诺医药－Ｂ行情,银诺医药－Ｂ股票行情,银诺医药－Ｂ股价,银诺医药－Ｂ股市,银诺医药－Ｂ股票价格,银诺医药－Ｂ股票交易,银诺医药－Ｂ股票购买,银诺医药－Ｂ股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"银诺医药－Ｂ(02591)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供银诺医药－Ｂ(02591)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}